Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

IL-33 is associated with alveolar dysfunction in patients with viral lower respiratory tract disease

Autor: Scott, Ian C. ^{a, ⁎}, Zuydam, Natalie van ^b, Cann, Jennifer A. ^c, Negri, Victor Augusti ^a, Tsafou, Kalliopi ^b, Killick, Helen ^a, Liu, Zhi ^d, McCrae, Christopher ^d, Rees, D. Gareth ^e, England, Elizabeth ^e, Guscott, Molly A. ^f, Houslay, Kirsty ^f, McCormick, Dominique ^g, Freeman, Anna ^h, Schofield, Darren ^e, Freeman, Adrian ^b, Cohen, E. Suzanne ^f, Thwaites, Ryan ⁱ, Brohawn, Zach ^d, Platt, Adam ^a, Openshaw, Peter J.M. ⁱ, Semple, Malcolm G. ^g, Baillie, J. Kenneth ^j, Wilkinson, Tom ^h

Publikováno v: In Mucosal Immunology December 2024

Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2).

Autor: Duncan P; Centre for Academic Primary Care, University of Bristol, Bristol, UK polly.duncan@bristol.ac.uk.; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Mears R; Centre for Academic Primary Care, University of Bristol, Bristol, UK.; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Begier E; Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, US., Rouhbakhsh Halvaei S; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Southern J; Evidence Generation, Pfizer Inc, Collegeville, PA, US., Porter SB; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Hubler R; Evidence Generation, Pfizer Inc, Collegeville, PA, US., Oben G; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Qian G; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Lahuerta M; Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, US., Davis T; Centre for Academic Primary Care, University of Bristol, Bristol, UK., Campling J; Vaccines Medical Affairs, Pfizer Ltd, Tadworth, UK., Dawson S; Centre for Academic Primary Care, University of Bristol, Bristol, UK., Christensen H; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Oliver J; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Morales-Aza B; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Pan K; EvGen Statistics, Pfizer Research and Development, Pfizer Inc, Collegeville, PA, US., Gray S; Evidence Generation, Pfizer Inc, Collegeville, PA, US., Hyams C; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Danon L; School of Engineering Mathematics and Technology, University of Bristol, Bristol, UK., Gessner BD; Global Respiratory Vaccines, Medical & Scientific Affairs, Pfizer Inc, Collegeville, PA, US.; West of England NIHR Clinical Research Network, Bristol, UK., Finn A; Bristol Vaccine Centre, Schools of Population Health Science and Cellular and Molecular Medicine, University of Bristol, Bristol, UK., Hay AD; Centre for Academic Primary Care, University of Bristol, Bristol, UK.

Publikováno v: BJGP open [BJGP Open] 2025 Jan 02; Vol. 8 (4). Date of Electronic Publication: 2025 Jan 02 (Print Publication: 2024).

Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices -- United States, 2023

Autor: Fleming-Dutra, Katherine E.¹ media@cdc.gov, Jones, Jefferson M.¹, Roper, Lauren E.¹, Prill, Mila M.¹, Ortega-Sanchez, Ismael R.¹, Moulia, Danielle L.¹, Wallace, Megan¹, Godfrey, Monica¹, Broder, Karen R.², Tepper, Naomi K.³, Brooks, Oliver⁴, Sánchez, Pablo J.⁵, Kotton, Camille N.⁶, Mahon, Barbara E.¹, Long, Sarah S.⁷, McMorrow, Meredith L.¹

Publikováno v: MMWR: Morbidity & Mortality Weekly Report. 10/13/2023, Vol. 72 Issue 41, p1115-1122. 8p. 1 Chart.